businesspress24.com - Brawijaya University develops GAD65 Rapid Test Diabetes Screening Kit
 

Brawijaya University develops GAD65 Rapid Test Diabetes Screening Kit

ID: 1562598

(firmenpresse) - Malang, East Java, Indonesia, Nov 25, 2020 - Brawijaya University (UB) in Malang, East Java has developed an initial screening kit for diabetes. The Bioscience Rapid Test GAD65, developed by aresearch team led by Prof. Dr. Aulanni'am, drh, DES, is ready for commercialization and use in early screening for Type I Diabetes Mellitus, before measures and treatment are determined.

The reverse-flow immunochromatography-based detection kit identifies the presence of autoantibodies against GAD65, which indicate damage to beta-pancreatic cells, a marker for Type 1 Diabetes Mellitus and Latent Autoimmune Diabetes in Adults (LADA).

Diabetes is a global health threat which can lead to complications that impact the quality of human life as well as substantially add to health costs for families and countries. Its increasing prevalence has raised concerns globally and prompted prevention efforts. Detecting and managing the condition through appropriate therapy is crucial for preventing deterioration in the condition of people suffering from the metabolic disease.

The Bioscience Rapid Test GAD65 is among the downstream products developed as part of the cooperation between Brawijaya University and state-owned pharmaceutical company PT Bio Farma (Persero). The preparation and production of the kit has involved various levels of research and testing, based on the consensus and regulations set by the World Health Organization (WHO) and the Indonesian Health Ministry.

The screening kit, which has a medical device distribution permit and meets the certification requirements for good medical device manufacturing from the Indonesian Ministry of Health, is ready to be produced and widely distributed and has been introduced to potential consumers in Spain, Taiwan, Japan, Saudi Arabia, Jordan, Madagascar, the Philippines, and Malaysia.

As part of the collaboration for the downstreaming process of the kit, Brawijaya University has been designated as the producer and PT Bio Farma as the main distributor of the patented product (ID. 0.022.556 B, 2009-Granted and P00201910578, 2019-Registered).





For further information, please contact:
Prof Dr. Aulanni'am, drh., DES
+62 812-3317-600
Public Relations,
Universitas Brawijaya
www.ub.ac.id
www.prasetya.ub.ac.id

Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Future Planet Capital invests in Navenio, Oxford’s ‘uber-for-indoors’, to control infection rise during COVID-19 and lower healthcare costs DETAK by Brawijaya University Researchers detects Heart Disease Early and Accurately
Bereitgestellt von Benutzer: acnnewswire
Datum: 25.11.2020 - 11:02 Uhr
Sprache: Deutsch
News-ID 1562598
Anzahl Zeichen: 2398

contact information:
Town:

Malang, East Java, Indonesia



Kategorie:

Healthcare & Medical


Typ of Press Release: Kooperation
type of sending: Veröffentlichung

Diese Pressemitteilung wurde bisher 566 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Brawijaya University develops GAD65 Rapid Test Diabetes Screening Kit"
steht unter der journalistisch-redaktionellen Verantwortung von

Brawijaya University (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Two new microalgae genera discovered in Indonesian waters ...

MALANG, E. JAVA, Indonesia, June 24, 2025 - (ACN Newswire) - A research team from Brawijaya University (UB) has identified two new microalgae genera in the waters around Bawean Island, Gresik Regency, East Java, and Tomini Bay, Central Sulawesi. & ...

Alle Meldungen von Brawijaya University



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 96


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.